Compare Tilray Brands Inc (TLRY) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs Tesla, Inc. — how do they compare? Tilray Brands Inc trades at $4.27 (market cap $524.07M), while Tesla, Inc. trades at $379.46 (market cap $1.39T). The key difference: Tesla, Inc. is far larger — about 2652.3× Tilray Brands Inc's market cap, and Tesla, Inc. is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | TSLA | |
|---|---|---|
Market Cap | $524.07M | $1.39T |
Sector | Health | Consumer Cyclical |
52-Week High | $21.00 | $489.88 |
52-Week Low | $4.23 | $302.63 |
Enterprise Value | $621.22M | $1.36T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.
The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.
Tesla trades at $378.99, down 0.49% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows elevated valuation ratios (P/E 339.06, P/S 13.34) despite recent earnings beats in Q4 2025 and Q1 2026. Revenue declined to $94.83B in 2025, with net income margin compressing to 3.95%. Positive developments include regulatory approval for driver-assistance software in Europe and a potential cheaper EV model, though delivery misses and competitive pressures weigh on sentiment.
Tesla's outlook balances innovation in autonomy and energy against slowing auto growth and high valuations. The consensus price target of $409.26 suggests modest upside, but risks include execution on robotaxis, margin pressure, and macroeconomic headwinds. Institutional ownership shifts and mixed analyst ratings (38% Buy, 43% Hold) reflect cautious optimism, with the stock's trajectory hinging on AI and energy segments offsetting EV deceleration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
